WPRIM Management System> DCMS> Chinese Journal of Cancer> 2013> 32

Volume: 32

1. Aberrant promoter CpG methylation and its translational applications in breast cancer. Page:12—20
2. Epigenetic changes in colorectal cancer. Page:21—30
3. Recent progress in the study of methylated tumor suppressor genes in gastric cancer. Page:31—41
4. Impact of genetic alterations on mTOR-targeted cancer therapy. Page:270—274
5. Liver cancer incidence and mortality in China, 2009. Page:162—169
6. Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery. Page:403—409
7. Malignant meningioma of the cerebellopontine angle in a 2-year-old girl: a case report and literature review. Page:415—417
8. Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells. Page:553—560
9. The incidences and mortalities of major cancers in China, 2009. Page:106—112
10. Pluripotency transcription factors and cancer stem cells: small genes make a big difference. Page:483—487
11. The VEGF signaling pathway in cancer: the road ahead. Page:297—302
12. Müllerian duct anomalies and their effect on the radiotherapeutic management of cervical cancer. Page:434—440
13. Autophagy and apoptosis: rivals or mates? Page:103—105
14. Hodgkin's lymphoma involving extranodal sites: potential association with HIV infection and the implications for clinical management. Page:102—102
15. Molecular markers as therapeutic targets in lung cancer. Page:59—62
16. Identification of SNP-containing regulatory motifs in the myelodysplastic syndromes model using SNP arrays and gene expression arrays. Page:170—185
17. B7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium. Page:653—660
18. Skeletal metastasis: treatments, mouse models, and the Wnt signaling. Page:380—396
19. The Sino-French 2012 Conference in Thoracic Oncology: an international academic platform for in-depth exchange on comprehensive research. Page:53—58
20. Small interfering RNA-based molecular therapy of cancers. Page:488—493
21. Mouse models of Mdm2 and Mdm4 and their clinical implications. Page:371—375
22. Discovery of molecular associations among aging, stem cells, and cancer based on gene expression profiling. Page:155—161
23. Complications of radical nephrectomy for renal cell carcinoma: a retrospective study comparing transperitoneal and retroperitoneal approaches using a standardized reporting methodology in two Chinese centers. Page:461—468
24. Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment. Page:312—324
25. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with conventional beams for nasopharyngeal carcinoma: a feasibility study. Page:397—402
26. Small nucleolar RNAs (snoRNAs) as potential non-invasive biomarkers for early cancer detection. Page:99—101
27. The absence of the ERBB4 hotspot mutations in melanomas in patients from southern China. Page:410—414
28. Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancer. Page:441—452
29. Using the theory of coevolution to predict protein-protein interactions in non-small cell lung cancer. Page:91—98
30. Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study. Page:325—333
31. Glioma-related edema: new insight into molecular mechanisms and their clinical implications. Page:49—52
32. Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment. Page:353—356
33. Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features. Page:303—311
34. The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations. Page:136—140
35. Detection and characterization of regulatory elements using probabilistic conditional random field and hidden Markov models. Page:186—194
36. GOMA: functional enrichment analysis tool based on GO modules. Page:195—204
37. Regulation of tumor cell migration by protein tyrosine phosphatase (PTP)-proline-, glutamate-, serine-,and threonine-rich sequence (PEST). Page:75—83
38. Dynamic protein-protein interaction subnetworks of lung cancer in cases with smoking history. Page:84—90
39. Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006. Page:512—519
40. The role of stem cells in airway repair: implications for the origins of lung cancer. Page:71—74
41. The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system. Page:342—352
42. The cellular decision between apoptosis and autophagy. Page:121—129
43. Managing esophageal fistulae by endoscopic transluminal drainage in esophageal cancer patients with superior mediastinal sepsis after esophagectomy. Page:469—473
44. Favorable prognosis of female patients with nasopharyngeal carcinoma. Page:283—288
45. Retroperitoneal schwannoma mimicking metastatic seminoma: case report and literature review. Page:149—152
46. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer. Page:289—296
47. Efficacy of minimally invasive therapies on unresectable pancreatic cancer. Page:334—341
48. Aberrant DNA methylation in cervical carcinogenesis. Page:42—48
49. Role of autophagy in acute myeloid leukemia therapy. Page:130—135
50. Targeting autophagic pathways for cancer drug discovery. Page:113—120
51. Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients. Page:213—223
52. The genetics and biology of KRAS in lung cancer. Page:63—70
53. Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma. Page:141—148
54. The propensity for tumorigenesis in human induced pluripotent stem cells is related with genomic instability. Page:205—212
55. Assessment of quality of life for the patients with cervical cancer at different clinical stages. Page:275—282
56. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma. Page:3—11
57. Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis. Page:604—613
58. Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment. Page:594—603
59. Noncoding RNAs in cancer and cancer stem cells. Page:582—593
60. Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies. Page:573—581
61. Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma. Page:525—532
62. Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer. Page:539—545
63. Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy. Page:494—501
64. An early history of human breast cancer: West meets East. Page:475—477
65. Nasopharyngeal carcinoma incidence and mortality in China in 2009. Page:453—460
66. The CUL4A ubiquitin ligase is a potential therapeutic target in skin cancer and other malignancies. Page:478—482
67. Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment. Page:546—552
68. Targeted therapy: tailoring cancer treatment. Page:363—364
69. Translational research in oncology research & development and its impact on early development in China: report of the 5th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at 2013 AACR Annual Meeting. Page:357—362
70. Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Page:502—511
71. Ubiquitin at the crossroad of cell death and survival. Page:640—647
72. Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis. Page:533—538
73. Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease. Page:673—677
74. The prognostic role of PRUNE2 in leiomyosarcoma. Page:648—652
75. Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies. Page:661—666
76. Investigating evolutionary perspective of carcinogenesis with single-cell transcriptome analysis. Page:636—639
77. Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance. Page:365—370
78. Clinical implications of microRNAs in liver cancer stem cells. Page:419—426
79. Intraarterial chemotherapy with gemcitabine and cisplatin in locally advanced or recurrent penile squamous cell carcinoma. Page:619—623
80. Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy. Page:376—379
81. Urinary bladder malignant paraganglioma with vertebral metastasis: a case report with literature review. Page:624—628
82. Dysregulation of mTOR activity through LKB1 inactivation. Page:427—433
83. Targeting the PI3K-AKT-mTOR signaling network in cancer. Page:253—265
84. Molecular targeted agents--where we are and where we are going. Page:225—232
85. Centrifugation: an important pre-analytic procedure that influences plasma microRNA quantification during blood processing. Page:667—672
86. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Page:614—618
87. Biological functions of decorin in cancer. Page:266—269
88. IGF-1R as an anti-cancer target--trials and tribulations. Page:242—252
89. Cancer research in an era when epigenetics is no longer "epi" - challenges and opportunities. Page:1—2
90. Cancer bioinformatics: detection of chromatin states, SNP-containing motifs, and functional enrichment modules. Page:153—154
91. A modified radiofrequency ablation approach for treating distant lymph node metastasis in two patients with late-stage cancer. Page:567—570
92. A Chinese patient with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin. Page:520—523
93. Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 cases. Page:561—566
94. sMICA and its emerging role as a prognostic and diagnostic indicator in systemic malignancies besides hepatocellular carcinoma. Page:224—224
95. New evidence-based adaptive clinical trial methods for optimally integrating predictive biomarkers into oncology clinical development programs. Page:233—241